Bongrani S, Razzetti R, Schiantarelli P
Arch Int Pharmacodyn Ther. 1985 Feb;273(2):226-36.
In this study the effects of intravenous nicardipine on the cardiovascular system in anaesthetized open chest dogs were assessed. In the dose range of 3-30 nmol/kg it induced a dose-dependent and long lasting reduction of the vertebral, coronary and femoral vascular resistance. Nicardipine proved to be equipotent, but longer lasting than nifedipine, and about 10 and 100 times more potent than verapamil and papaverine respectively. Unlike papaverine, calcium entry blockers caused a preferential vasodilation of the vertebral and coronary arteries. Hypotension and a reduction of LVSP and dP/dt appeared only at the highest dose tested. However, for both dihydropyridine derivatives, in contrast to verapamil, the cardiodepressant effects were short-lived and resulted less marked for nicardipine than for nifedipine.
在本研究中,评估了静脉注射尼卡地平对麻醉开胸犬心血管系统的影响。在3 - 30 nmol/kg的剂量范围内,它可引起椎动脉、冠状动脉和股血管阻力呈剂量依赖性且持久的降低。尼卡地平被证明具有同等效力,但作用时间比硝苯地平更长,分别比维拉帕米和罂粟碱强约10倍和100倍。与罂粟碱不同,钙通道阻滞剂可使椎动脉和冠状动脉优先扩张。仅在测试的最高剂量下出现低血压以及左心室收缩压(LVSP)和dp/dt降低。然而,与维拉帕米相比,两种二氢吡啶衍生物的心脏抑制作用都是短暂的,且尼卡地平的作用不如硝苯地平明显。